stella
beta
Safety and Immunogenicity Study of Three mRNAs Encoding HIV Immunogens in Adult Participants Without HIV and in Overall Good Health in South Africa. — Stella
Recruiting
Back to HIV Infections trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(6 sites)
South Africa
Setshaba Research Centre CRS, Soshanguve, Gauteng
Perinatal HIV Research Unit (PHRU), Soweto, Gauteng
CAPRISA eThekwini CRS, Durban, KwaZulu-Natal
Isipingo CRS, Isipingo, KwaZulu-Natal
Desmond Tutu Health Foundation Emavundleni CRS, Cape Town, Western Cape
Show all 6 locations
View full record on ClinicalTrials.gov